実績

Costs and Resource Use Associated with Community-Dwelling Patients withAlzheimer's Disease in Japan: Baseline Results from the Prospective ObservationalGERAS-J Study.

Japan society of clinical oncology/Japanese society of medical oncology-ledclinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosinekinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology.

Efficacy and safety of tacrolimus in patients with rheumatoid arthritis - Asystematic review and meta-analysis.

Epidemiological characteristics of rheumatoid arthritis in Japan: Prevalenceestimates using a nationwide population-based questionnaire survey.

A Cost-Effectiveness Analysis Of Pregabalin For The Treatment Of Patients WithChronic Cervical Pain With A Neuropathic Component In Japan.

Malnutrition-Related Health Care Cost in Japan: An Analysis of Health InsuranceClaims Data.

Cost-utility analysis of a 'vonoprazan-first' strategy versus 'esomeprazole- orrabeprazole-first' strategy in GERD.

Cost-minimisation model of magnetic resonance-guided focussed ultrasound therapy compared to unilateral deep brain stimulation for essential tremor treatment inJapan.

Willingness to pay for QALY: perspectives and contexts in Japan.

Cost-effectiveness analysis of sofosbuvir plus ribavirin in patients withgenotype 2 chronic hepatitis C: an analysis with real world outcomes from amulticentre cohort in Japan.

Effectiveness of pregabalin for treatment of chronic cervical radiculopathy with upper limb radiating pain: an 8-week, multicenter prospective observational studyin Japanese primary care settings.

A retrospective cohort study evaluating healthcare resource utilization inpatients with asthma in Japan.

Systematic review with network meta-analysis: indirect comparison of the efficacyof vonoprazan and proton-pump inhibitors for maintenance treatment ofgastroesophageal reflux disease.

Vonoprazan versus proton-pump inhibitors for healing gastroesophageal refluxdisease: A systematic review.

Cost-effectiveness analysis of postpolypectomy colonoscopy surveillance usingJapanese data.

Evaluating the cost-effectiveness of secukinumab in moderate-to-severe psoriasis:a Japanese perspective.

COPD uncovered: a cross-sectional study to assess the socioeconomic burden ofCOPD in Japan.

The association between smoking cessation outpatient visits and total medicalcosts: a retrospective, observational analysis of Japanese employee-based public health insurance data.

Economic impact of adalimumab treatment in Japanese patients with rheumatoidarthritis from the adalimumab non-interventional trial for up-verified effectsand utility (ANOUVEAU) study.

Attitudes towards passive smoking at restaurants and effects of the provision of information: A comparison between smokers and non-smokers via a web survey.

Transforming Latent Utilities to Health Utilities: East Does Not Meet West.

Cost-utility analysis of ledipasvir/sofosbuvir for the treatment of genotype 1chronic hepatitis C in Japan.

Cost-utility analysis of sofosbuvir for the treatment of genotype 2 chronichepatitis C in Japan.

A cost-utility analysis for catheter ablation of atrial fibrillation incombination with warfarin and dabigatran based on the CHADS2 score in Japan.

Attitudes towards passive smoking at restaurants and effects of the provision of information: A comparison between smokers and non-smokers via a web survey.

Examining the association of smoking with work productivity and associated costs in Japan.

An exploration of differences between Japan and two European countries in theself-reporting and valuation of pain and discomfort on the EQ-5D.

Impact of Adalimumab on Work Productivity and Activity Impairment in JapanesePatients with Rheumatoid Arthritis: Large-Scale, Prospective, Single-CohortANOUVEAU Study.

Integrating patients' perceptions into clinical practice guidelines for themanagement of rheumatoid arthritis in Japan.

Transforming Latent Utilities to Health Utilities: East Does Not Meet West.

Cost-utility analysis of ledipasvir/sofosbuvir for the treatment of genotype 1chronic hepatitis C in Japan.

Cost-utility analysis of sofosbuvir for the treatment of genotype 2 chronichepatitis C in Japan.

[Universal Health Coverage and Cancer Drugs - A Cost-Effectiveness Perspective].

Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L HealthStates in Japan.

Comparative Effectiveness of Oral Medications for Pulmonary ArterialHypertension.

Cost-effectiveness of direct-acting antiviral regimenombitasvir/paritaprevir/ritonavir in treatment-naive and treatment-experiencedpatients infected with chronic hepatitis C virus genotype 1b in Japan.

Optimal use of colonoscopy and fecal immunochemical test for population-basedcolorectal cancer screening: a cost-effectiveness analysis using Japanese data.

Cost-Effectiveness Analysis of Smoking Cessation Interventions in Japan Using aDiscrete-Event Simulation.

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D.

The process of collecting and evaluating evidences for the development ofGuidelines for the management of rheumatoid arthritis, Japan College ofRheumatology 2014: Utilization of GRADE approach.

Profiles of EQ-5D utility scores in the daily practice of Japanese patients with rheumatoid arthritis; Analysis of the IORRA database.

Effects of Prescription Drug Reduction on Quality of Life in Community-DwellingPatients with Dementia.

Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan.

Effectiveness of pregabalin for the treatment of chronic low back pain withaccompanying lower limb pain (neuropathic component): a non-interventional study in Japan.

Cost-utility analysis of an advanced pressure ulcer management protocol followed by trained wound, ostomy, and continence nurses.

Comparison of the Effects of a Brand-name Drug and Its Generic Drug on theQuality of Life of Alzheimer's Disease Patients.

Relationship between health literacy, health information access, health behavior,and health status in Japanese people.

Postoperative complications in patients with rheumatoid arthritis using abiological agent - A systematic review and meta-analysis.

Cost-minimization analysis of IgPro20, a subcutaneous immunoglobulin, in Japanesepatients with primary immunodeficiency.

[Pharmacoeconomics of molecular targeting drugs].

Web-based survey on smoking cessation behaviors of current and former smokers in Japan.

Cost-Effectiveness Analysis of CT Colonography for Colorectal Cancer ScreeningProgram to Working Age in Japan.

Validity and reliability of the Japanese version of the Newest Vital Sign: apreliminary study.

Validity and reliability of the Japanese version of the Newest Vital Sign: apreliminary study.

WTP for a QALY and health states: More money for severer health states?

The 14-item health literacy scale for Japanese adults (HLS-14).

Cost-effectiveness analysis of microdose clinical trials in drug development.

Analysis of direct medical and nonmedical costs for care of rheumatoid arthritis patients using the large cohort database, IORRA.

Drug Utilization Reviews by Community Pharmacists in Japan: Identification ofPotential Safety Concerns through the Brown Bag Program.